RESPONSABILI SCIENTIFICI: Irma Bisceglia (Roma), Furio Colivicchi (Roma), Domenico Gabrielli (Roma)
- cardiotoxicities induced by antineoplastic therapies and their more appropriate management;
- the most frequent complications that the cardiologist has to face in cancer patients (atrial fibrillation, long QT, pericardial effusions, venous thromboembolism) and related treatment.
In this period of COVID-19 pandemic it is necessary to reduce the risk of infection for patients, maintaining high standards of care in treating cancer and cardiovascular complications, therefore, monitoring protocols are being defined for a more targeted use of imaging, greater use of biomarkers and telemedicine.
© All Rights Reserved